Navigation Links
VA Deploying Assessment Team to Marion Medical Center
Date:11/6/2007

Report To Supplement Ongoing Investigation

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- A multi-disciplinary assessment team will be sent to the Department of Veterans Affairs (VA) Marion, Ill., Hospital to review recent allegations made by hospital employees relating to operations at the facility, the Department announced today.

The team will assess personnel practices and procedures at the facility; review issues related to equal employment opportunity; assess how well employees and managers are communicating; and evaluate how well the facility is implementing hiring processes and procedures.

"VA is committed to providing quality care to veterans," said Gordon H. Mansfield, Acting Secretary of Veterans Affairs. "We are also committed to ensuring all laws related to federal employees are fully enforced. The assessment team will make certain we are doing what's right for both veterans and VA employees."

The Assessment Team will include experts from human resources, employee and labor relations experts; a representative from VHA's National Center for Organizational Development; a representative from VA's Office of General Counsel; an environment of care expert; an Office of Resolution Management representative; and VA leaders and managers from other health care facilities. The team is expected to be on-site within one week and composed of seven to 10 members.

Team members will also assess the impact of issues that have already been raised at Marion on the manner in which care is delivered to veterans at the hospital, and will educate employees about issues they have raised concerning possible retaliation.

Upon completion of their review, team members will provide recommendations for improvements at the facility to Acting Secretary Mansfield. They will also suggest follow-up activities to ensure their recommendations are fully implemented.

VA began its review of issues at Marion as a result of a June 2007 statis
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Researcher developing new method for hearing loss assessment
2. Supplier Assessments to Help Buyers Identify Reliable China Exporters
3. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
4. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
5. AHIMA Signs Contract With CMS for ICD-10 Implementation Assessment and Training
6. M-POSSUM, an effective risk assessment system prior to operation
7. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
8. PinnacleHealth System Selects Phoenix Health Systems to Provide HIPAA Security Assessment Services
9. AssistNow Offers Area Employers Complimentary Needs Assessment in Recognition of National Drug-Free Work Week
10. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
11. Hooper Holmes Introduces Mature Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Newswire-USNewswire/ -- New research at West Virg... spitless tobacco product aimed at young adults is...RJ Reynolds, Camel Snus - touted as a socially acc...singly high levels of nicotine. , , "Camel ...products," said Bruce Adkins of the state Division...
(Date:11/21/2008)...swire-USNewswire/ -- U.S. News & World Report ...NCQA) ranked BlueChoice(R) HealthPlan of South Car...ans(TM), published in U.S. News & World Report...l ranking ranks the nation,s best health plans bas...QA accreditation scores. NCQA and U.S. News & ...
(Date:11/21/2008)...swire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NY...overwhelmingly approved the proposals submitted to...Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )....elming support of the transaction by the Barr shar...nd CEO. "We are pleased with the progress that we ...
(Date:11/21/2008)...y diseaseits cause remains a mysteryswept into Ath...citizens, soldiers and refugees of the war then ra...with corpses, social order broke down. Over the ne...ens lost a third of its population. It lost the wa...f the end of the Golden Age of Greece. , The Pl...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ons running at double the number of what they were...e reached an all time high//.Deaths due to alcohol...ast five years, Government sources revealed. Off...compiled for the NHS, found that 35,400 people wer...
...aving several older brothers increases the chances...t adds //weight to the idea of a biological basis ...rock University in St Catharines, Canada said, "It...and other studies suggest that there is probably a...
...eported by residents living near the former VA Tec... the massive fire which ripped// through this indu...mon health problems such as eczema, asthma, psoria...r environment and health experts have found no evi...
...re found to be associated with reduced length of a... community-acquired //pneumonia (CAP) – Study find...ed to be a good indicator for early discontinuance...red with other parameters. The study, which is th...
Other Medicine News:Health News:Alcohol-Related Illnesses On The Rise 2Health News:No Clue to Cause of Mystery Illnesses 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 3
(Date:11/20/2008)... New Jersey American Water has lifted the precaut...he following municipalities in Middlesex, Somerset..., , , Dunellen , Edison , ...lainfield , , , , Somerset County ,...er , Green Brook , Hillsborough , ...
(Date:11/20/2008)...ewswire-FirstCall/ -- Arpida (SWX:,ARPN) announce...mittee of the,U.S. Food and Drug Administration (...travenous iclaprim, an antibiotic currently in dev...icated skin and skin structure infections,(cSSSIs... Staphylococcus,aureus (MRSA). , Arpida re...
(Date:11/20/2008)...tCall/ -- Duska Therapeutics,Inc., (OTC Bulletin...ed its,pivotal Phase 3 ATPace clinical trial prot...nt (SPA) procedure with the U.S. Food and Drug Adm...n agreement with the FDA, Duska intends to initiat...ntrolled and randomized Phase 3,clinical trial wi...
(Date:11/20/2008)...PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has opened an offic...nd clinical research capabilities. With the additi...hroughout five important biopharmaceutical centers...razil, Chile, and Mexico. This expansion further s...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Chemo for Mesothelioma Offers Limited Survival Benefits 19551 1Chemo for Mesothelioma Offers Limited Survival Benefits 19551 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 1Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 3Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 4Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 5Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 6Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 7Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 8Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 9AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 1AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 1Senetek PLC Reports First Quarter 2008 Financial Results 5462 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 3
...D Are at High,Risk , ,WASHINGTON, March 9, 2007 ...family history of end-stage renal disease (ESRD), ...sk of developing,kidney disease themselves, report...iety of Nephrology. , "A family history of kidney ... are also at substantially higher risk of,ESRD," c...
...07 /PRNewswire-FirstCall/ - Chemokine,Therapeutics... , a,biotechnology company developing chemokine-ba...d vascular disease today announced,positive prelim...se-escalation portion of its Phase Ib/II clinical ...g candidate. No dose,limiting toxicities were obse...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...even digital models cover the range from 2ul to 50...ume lock design prevents inadvertent volume change...ip. Whole pipette is autoclavable at 121C(250F). ...ropylene. Suitable for one-handed operation. Aut...
...he AlphaPette Pipettor is the #1 Pipettor for sub-...comfort, and reliability. Continuously adjustable....dout sub-micrometer. Easy interchangeable ejector ...le rapid pipet tip ejector with three different le...
Medicine Products: